Northern Trust
ARIA

Northern Trust’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Northern Trust’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,093,677
Closed -$26M – 4323
2016
Q4 		$26M Sell
2,093,677
-185,625
-8% -$2.24M 0.01% 1404
2016
Q3 		$31.2M Buy
2,279,302
+59,854
+3% +$601K 0.01% 1215
2016
Q2 		$16.4M Buy
2,219,448
+86,396
+4% +$648K 0.01% 1681
2016
Q1 		$13.5M Buy
2,133,052
+38,462
+2% +$216K ﹤0.01% 1758
2015
Q4 		$13.1M Buy
2,094,590
+23,023
+1% +$151K ﹤0.01% 1803
2015
Q3 		$12.1M Sell
2,071,567
-67,189
-3% -$518K ﹤0.01% 1851
2015
Q2 		$17.7M Buy
2,138,756
+95,800
+5% +$847K 0.01% 1681
2015
Q1 		$16.8M Buy
2,042,956
+30,322
+2% +$224K 0.01% 1712
2014
Q4 		$13.8M Sell
2,012,634
-76,364
-4% -$478K ﹤0.01% 1817
2014
Q3 		$11.3M Buy
2,088,998
+1,104,388
+112% +$6.45M ﹤0.01% 1946
2014
Q2 		$6.27M Sell
984,610
-1,921
-0.2% -$13.2K ﹤0.01% 2370
2014
Q1 		$7.95M Buy
986,531
+194,825
+25% +$1.52M ﹤0.01% 2263
2013
Q4 		$5.4M Buy
791,706
+12,734
+2% +$68.8K ﹤0.01% 2511
2013
Q3 		$14.3M Sell
778,972
-52,148
-6% -$1.01M 0.01% 1746
2013
Q2 		$14.5M Buy
+831,120
New +$14.7M 0.01% 1619

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Northern Trust's ARIA Position: Q1 2017 in Review

Northern Trust sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 2,093,677 shares — an estimated $26M sold.

Northern Trust first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $31.2M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Northern Trust reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Northern Trust sold 2,093,677 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $26M.
  • Northern Trust first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Northern Trust's Ariad Pharmaceuticals Inc position peaked at $31.2M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Northern Trust's 13F filing for Q1 2017, filed 12 May 2017.